PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CURE vs. XLV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


CUREXLV
YTD Return3.83%2.97%
1Y Return7.26%7.98%
3Y Return (Ann)3.56%5.96%
5Y Return (Ann)16.87%11.39%
10Y Return (Ann)19.21%11.05%
Sharpe Ratio0.090.60
Daily Std Dev31.71%10.69%
Max Drawdown-69.19%-39.18%
Current Drawdown-26.53%-5.29%

Correlation

-0.50.00.51.01.0

The correlation between CURE and XLV is 0.98, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

CURE vs. XLV - Performance Comparison

In the year-to-date period, CURE achieves a 3.83% return, which is significantly higher than XLV's 2.97% return. Over the past 10 years, CURE has outperformed XLV with an annualized return of 19.21%, while XLV has yielded a comparatively lower 11.05% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%70.00%NovemberDecember2024FebruaryMarchApril
38.99%
14.55%
CURE
XLV

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Direxion Daily Healthcare Bull 3x Shares

Health Care Select Sector SPDR Fund

CURE vs. XLV - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than XLV's 0.12% expense ratio.


CURE
Direxion Daily Healthcare Bull 3x Shares
Expense ratio chart for CURE: current value at 1.08% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.08%
Expense ratio chart for XLV: current value at 0.12% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.12%

Risk-Adjusted Performance

CURE vs. XLV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CURE
Sharpe ratio
The chart of Sharpe ratio for CURE, currently valued at 0.09, compared to the broader market-1.000.001.002.003.004.000.09
Sortino ratio
The chart of Sortino ratio for CURE, currently valued at 0.36, compared to the broader market-2.000.002.004.006.008.000.36
Omega ratio
The chart of Omega ratio for CURE, currently valued at 1.04, compared to the broader market1.001.502.001.04
Calmar ratio
The chart of Calmar ratio for CURE, currently valued at 0.06, compared to the broader market0.002.004.006.008.0010.000.06
Martin ratio
The chart of Martin ratio for CURE, currently valued at 0.27, compared to the broader market0.0010.0020.0030.0040.0050.0060.000.27
XLV
Sharpe ratio
The chart of Sharpe ratio for XLV, currently valued at 0.60, compared to the broader market-1.000.001.002.003.004.000.60
Sortino ratio
The chart of Sortino ratio for XLV, currently valued at 0.93, compared to the broader market-2.000.002.004.006.008.000.93
Omega ratio
The chart of Omega ratio for XLV, currently valued at 1.11, compared to the broader market1.001.502.001.11
Calmar ratio
The chart of Calmar ratio for XLV, currently valued at 0.55, compared to the broader market0.002.004.006.008.0010.000.55
Martin ratio
The chart of Martin ratio for XLV, currently valued at 2.02, compared to the broader market0.0010.0020.0030.0040.0050.0060.002.02

CURE vs. XLV - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 0.09, which is lower than the XLV Sharpe Ratio of 0.60. The chart below compares the 12-month rolling Sharpe Ratio of CURE and XLV.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00NovemberDecember2024FebruaryMarchApril
0.09
0.60
CURE
XLV

Dividends

CURE vs. XLV - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.82%, more than XLV's 1.57% yield.


TTM20232022202120202019201820172016201520142013
CURE
Direxion Daily Healthcare Bull 3x Shares
1.82%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%0.00%0.00%1.24%
XLV
Health Care Select Sector SPDR Fund
1.57%1.59%1.47%1.33%1.49%2.16%1.56%1.46%1.59%1.43%1.34%1.51%

Drawdowns

CURE vs. XLV - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, which is greater than XLV's maximum drawdown of -39.18%. Use the drawdown chart below to compare losses from any high point for CURE and XLV. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2024FebruaryMarchApril
-26.53%
-5.29%
CURE
XLV

Volatility

CURE vs. XLV - Volatility Comparison

Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 11.16% compared to Health Care Select Sector SPDR Fund (XLV) at 3.79%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%NovemberDecember2024FebruaryMarchApril
11.16%
3.79%
CURE
XLV